Xiaoning Wu

机构：Guangxi Medical University · ORCID：0000-0001-5416-712X

发表论文 163 篇 · 总被引 2113 次 · h-index 26

代表论文

• Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled study (2025 · Hepatology · 被引 10)
• Serological proteomic characterization for monitoring liver fibrosis regression in chronic hepatitis B patients on treatment (2025 · Nature Communications · 被引 5)
• Unstable Recompensation: An Intermediate Subtype in Patients With HBV ‐Related Decompensated Cirrhosis (2025 · Alimentary Pharmacology & Therapeutics · 被引 4)
• Dynamics of holographic steady flows near a first-order phase transition (2025 · Science China Physics Mechanics and Astronomy · 被引 4)
• Early on-treatment LSM reliably predicts liver-related events in CHB patients with significant fibrosis and cirrhosis (2025 · Hepatology · 被引 3)
• Multiple Low‐Level Viraemia Suggest Hindered Liver Fibrosis Regression in Chronic Hepatitis B Patients During Antiviral Therapy (2024 · Journal of Viral Hepatitis · 被引 3)